期刊文献+

HIV/AIDS病人CD_4^+T淋巴细胞计数与HDL-C水平的相关性 被引量:1

Correlation of CD_4^+ T lymphocytes and HDL-C levels in HIV/AIDS patients
原文传递
导出
摘要 目的探讨未经高效抗反转录病毒治疗(HAART)的艾滋病病毒(HIV)感染者/艾滋病(AIDS)病人(HIV/AIDS病人),不同CD+4T淋巴细胞(CD4细胞)水平的高密度脂蛋白胆固醇(HDL-C)的水平。方法选择未进行HAART的HIV/AIDS病人,同时检测CD4细胞计数和空腹血脂水平,比较不同CD4细胞水平的HIV/AIDS病人的血脂水平,重点观察HDL-C的变化。结果 CD4细胞计数与HDL-C水平呈正相关(P<0.01),CD4细胞计数>200/μL组的107例病人的HDL-C为(1.02±0.29)mmol/L,≤200/μL组的139例病人的HDL-C为(0.84±0.35)mmol/L,≤200/μL病人的HDL-C较>200/μL病人明显降低(P<0.01)。而CD4细胞计数在200~51/μL的病人HDL-C为(0.96±0.30)mmol/L,≤50/μL的病人HDL-C为(0.72±0.36)mmol/L,≤50/μL的HDL-C降低更明显(P<0.01)。结论 HIV感染可导致血脂异常,HAART之前的HIV/AIDS病人中,主要是HDL-C及载脂蛋白A1的降低,随着CD4细胞计数减少,HDL-C水平随之降低,心血管疾病(CVD)的危险随之升高。 Objective To explore HDL-C levels of HAART-naive human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) patients with diverse CD4 cell counts. Methods The fasting serum lipid levels and CD4 cell counts were tested simultaneously, serum lipid levels with diverse CD4 cell counts were compared, especially HDL-C. Results CD4 cell counts were positively correlated with HDL-C levels. HDL-C of patients with CD4 cell counts〉200/μL was 1.02±0.29 mmol/L, and HDL-C of patients with CD4 cell counts ≤ 200 /μL was 0.84±0.35 mmol/L. HDL-C levels of patients with CD4 cell counts ≤ 200/μL were distinctly lower than those of patients with CD4 cell counts 〉200μL. Furthermore, HDL-C of patients with CD4 cell counts between 51 and 200μL was 0.96±0.30mmol/L, and HDL-C of patients with CD4 cell counts ≤50/μL was 0.72±0.36 mmol/ L. HDL-C of patients with CD4 cell counts≤50/μL was even lower. The statistical difference was significant(P〈 0.01). Conclusions HIV infection leads to dyslipidemia. HDL-C and ApoA1 usually reduce before HAART. HDL C level declines and the risk of cardiovascular disease (CVD) rises with the decrease of CD4 cell counts.
出处 《中国艾滋病性病》 CAS 2014年第1期2-5,共4页 Chinese Journal of Aids & STD
基金 北京市朝阳区艾滋病和病毒性肝炎等重大传染病综合防治示范区建设研究(2012ZX10004-904) 北京市卫生系统高层次人才资助~~
  • 相关文献

参考文献22

  • 1Asztalos BF, Schaefer EJ, Horvath KV,et al. Protease inhibitor- base HAART, HDL-C, and CHD-risk in H1V-infected patiesns rJ]. Atherosclerosis, 2006,184 ( 1 ) : 72- 77.
  • 2肖江,郜桂菊,李鑫,韩宁,刘龙,杨涤,张黎颖,赵红心,毛羽.高效抗逆转录病毒治疗对艾滋病患者机体代谢的影响[J].中华实验和临床感染病杂志(电子版),2011,5(2):5-10. 被引量:21
  • 3中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南[J].中国心血管病杂志,2007,35(5):390-409.
  • 4中华医学会感染病学分会艾滋病分组.艾滋病诊疗指南[J].中华传染病杂志,2011,29(1):629-639.
  • 5Riddler SA, Smit E, Cole SR, etal. HAART on serum lipids in men[J] 2878-2982. Impact of HIV infection and JAMA, 2003, 289(22).
  • 6Syed SS, Ralluz RS, Kabagambe EK, et al. Assessment of Biomar- kers of Cardiovascular Risk Among HIV Type 1-Infected Adoles- cents: Role of Soluble Vascular Cell Adhesion Molecule As an Early Indicator of Endothelial Inflammation[-J]. AIDS Res Hum Retroviruses,2013 ,29(3) :493-500.
  • 7Borato DC, Parabocz GC, Ribas SR,et al. Changes of metabolic and inflammatory markers in HIVinfection: glucose, lipids, se- rumHs-CRPandmyeloperoxidase[-J]. Metabolism, 2012,61 ( 10 ) : 1353-1360.
  • 8Manvthu EM,Joshi MD , Lule GN, et al. Prevalence of dyslipi- demia in HIV infected patientsT-J]. East Aft Med J,2008,85(1) : 10-17.
  • 9Carr A, Emery S, Law M,etal. An objective case definition of li- podysrophy in HIV-infected adults: a case-control study[-J]. Lan- cet,2003, 361(9359), 726-735.
  • 10EI-Sadr WM, Mullin CM, Carr A,et al. Effect of HIV disease on lipid, glucose and insulin levels: results from a large antiret- roviral-naive cohortFJ3. HIV Medicine ,2005,6(2) : 114- 121.

二级参考文献14

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 2王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:630
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 4Ankit Parakh,Anand Prakash Dubey,Ajay Kumar,Anshu Maheshwari.Lipodystrophy and metabolic complications of highly active antiretroviral therapy[J]. The Indian Journal of Pediatrics . 2009 (10)
  • 5Manfredi R.Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients:role of o-mega-3polyunsaturated fatty acids at different dosages,compared with fibrates. International Journal of STD and AIDS . 2010
  • 6Aghdassi E,Arendt BM,Salit IE,et al.In patients with HIV-infection,chromium supplementation improves insulin resistance and other metabolic abnormalities:a randomized,double-blind,placebo controlled trial. Current Hiv Research . 2010
  • 7Reinsch N,Neuhaus K,,Esser S,et al.Prevalence of cardiac diastolic dysfunction in HIV-infected patients:results of the HIV-HEARTstudy. HIV Clinical Trials . 2010
  • 8Guaraldi G,Stentarelli C,Orlando G,et al.Nonalcoholic fatty liver disease in HIV-infected persons:epidemiology and the role of nucleoside reverse transcriptase inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes . 2010
  • 9Lampe FC,Duprez DA,Kuller LH,et al.Changes in lipids and lipoprotein particle concentrations after interruption of antiretro-viral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes . 2010
  • 10Turner JJ,Foxwell KM,Kanji R,et al.Investigation of nuclear factor-κB inhibitors and interleukin-10as regulators of inflamma-tory signalling in human adipocytes. Clinical and Experimental Immunology . 2010

共引文献23

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部